Nitric BioTherapeutics
Bristol, US
Founders & leadership
FJ
Frank J. McCaneyExecutive
JR
James RatiganExecutive
Board
AO
Adele OlivaBoard director
AA
Al AltomariBoard director
JO
Jeffrey O'DonnellBoard director
ZS
Zev ScherlBoard director
BM
Brian M. GallagherBoard director
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2012
▶$1MraisedJan 2012 · 4 investors · BiotechnologyRule 506(b)
▶$1MraisedJan 2012 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank J. McCaneyExecutive Officer, Director
- Al AltomariDirector
- Adele OlivaDirector
- Jeffrey O'DonnellDirector
- Zev ScherlDirector
- Brian M. GallagherDirector
- James RatiganExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $1M
- First sale
- Jan 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 05, 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Nitric BioTherapeutics raised?
- Nitric BioTherapeutics has disclosed $1M raised across 1 round.
- Where is Nitric BioTherapeutics headquartered?
- Nitric BioTherapeutics is headquartered in Bristol, US.